Evidence map›Paper›PMID 30930671›Full record

ArticleSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society

Recurrent unicystic maxillary ameloblastoma presenting as unilateral proptosis.

K Al Qahtani, A F Alkhudhayri, T Islam, K Al Mufargi, W Al Shakweer, F Otaibi

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

K Al QahtaniDepartment of Otolaryngology, Head & Neck Surgery King, Abdul-Aziz University Hospital, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
A F AlkhudhayriDepartment of Otolaryngology - Head and Neck Surgery, Riyadh, King Fahad Medical City, Saudi Arabia.
T IslamCollege of Medicine and Research Center, King Saud University, Riyadh, Saudi Arabia.
K Al MufargiDepartment of Otolaryngology - Head and Neck Surgery, Riyadh, King Fahad Medical City, Saudi Arabia.
W Al ShakweerDepartment of Pathology, Riyadh, King Fahad Medical City, Saudi Arabia.
F OtaibiDepartment of Otolaryngology - Head and Neck Surgery, Riyadh, King Fahad Medical City, Saudi Arabia.
King Fahd Medical City · SAKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unicystic Ameloblastoma (UA) is a rare variant of ameloblastoma which is an odontogenic epithelial neoplasm, typically affecting mandibular ramus. Maxillary ameloblastoma is a rare entity with a more disastrous consequence. Although extremely rare, their highly recurrent and locally aggressive behavior can lead to invasion of vital structures surrounding maxilla (orbit, cranium) even after several years of conservative surgical management (limited resection, curettage). We report a case of 16-year-old girl presenting with proptosis of left eye, UA left maxilla, who was treated initially with limited resection (enucleation) and curettage and the lesion recurred after two years with a more aggressive behavior, causing destruction floor of orbit. To this date there are only 23 documented cases of orbital invasion and only three of the reports are in ophthalmic literature. The ophthalmologists need to be aware of this type of rare lesion presenting as proptosis.

Indexed as

Maxillary ameloblastomaOrbitProptosisUnicystic ameloblastoma

Identifiers

PMID30930671
PMCPMC6424681
OpenAlexW2856281597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.